PAT and the development of advanced control systems for pharmaceutical manufacturing processes. The FDA-Pizer CRADA
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Presentation
- By: HAMMOND, Stephen (Pfizer, Morris Plains, United States of America)
Abstract Pfizer Global Manufacturing has a strategic objective to strive for "Right First Time Performance" in our operations. The objective includes the elimination of variability within the processes we operate, thus reducing variability in the products the processes deliver. Key to achieving RFT performance is the use of PAT to better.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.